Photo of Shipra Gandhi from medicine.buffalo.edu
Nov 22, 2023, 16:06
Shipra Gandhi: How a novel strategy can modulate the chemokine milieu in the TME
Shipra Gandhi, Translational Researcher at Roswell Park Comprehensive Cancer Center, shared a post by Journal for ImmunoTherapy of Cancer on X/Twitter, adding:
”We are excited to share our findings from a clinical trial in TNBC showing how a novel strategy can modulate the chemokine milieu in the TME.”
Quoting Journal for ImmunoTherapy of Cancer‘s post:
”New JITC article: Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor micro environments for selective CTL influx.”
For the article click here.
Source: Shipra Gandhi/Twitter and Journal for ImmunoTherapy of Cancer/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46